SGTX - Sigilon Therapeutics GAAP EPS of -$0.23 in-line revenue of $4.86M beats by $1.76M May, 09 2023 08:53 AM Sigilon Therapeutics Inc. 2023-05-09 08:53:13 ET Sigilon Therapeutics press release ( NASDAQ: SGTX ): Q1 GAAP EPS of -$0.23 in-line. Revenue of $4.86M (+53.3% Y/Y) beats by $1.76M . For further details see: Sigilon Therapeutics GAAP EPS of -$0.23 in-line, revenue of $4.86M beats by $1.76M